ISPAD Clinical Practice Consensus Guidelines
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state
Joseph I. Wolfsdorf,
Nicole Glaser,
Michael Agus,
Maria Fritsch,
Ragnar Hanas,
Arleta Rewers,
Mark A. Sperling,
Ethel Codner,
Corresponding Author
Joseph I. Wolfsdorf
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts
Correspondence
Joseph I. Wolfsdorf, Division of Endocrinology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA.
Email: [email protected]
Search for more papers by this authorNicole Glaser
Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, California
Search for more papers by this authorMichael Agus
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts
Division of Critical Care Medicine, Boston Children's Hospital, Boston, Massachusetts
Search for more papers by this authorMaria Fritsch
Department of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorRagnar Hanas
Department of Pediatrics, NU Hospital Group, Uddevalla and Sahlgrenska Academy, Gothenburg University, Uddevalla, Sweden
Search for more papers by this authorArleta Rewers
Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado
Search for more papers by this authorMark A. Sperling
Division of Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York
Search for more papers by this authorEthel Codner
Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile
Search for more papers by this authorJoseph I. Wolfsdorf,
Nicole Glaser,
Michael Agus,
Maria Fritsch,
Ragnar Hanas,
Arleta Rewers,
Mark A. Sperling,
Ethel Codner,
Corresponding Author
Joseph I. Wolfsdorf
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts
Correspondence
Joseph I. Wolfsdorf, Division of Endocrinology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA.
Email: [email protected]
Search for more papers by this authorNicole Glaser
Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, California
Search for more papers by this authorMichael Agus
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts
Division of Critical Care Medicine, Boston Children's Hospital, Boston, Massachusetts
Search for more papers by this authorMaria Fritsch
Department of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
Search for more papers by this authorRagnar Hanas
Department of Pediatrics, NU Hospital Group, Uddevalla and Sahlgrenska Academy, Gothenburg University, Uddevalla, Sweden
Search for more papers by this authorArleta Rewers
Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado
Search for more papers by this authorMark A. Sperling
Division of Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York
Search for more papers by this authorEthel Codner
Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile
Search for more papers by this author
REFERENCES
- 1Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983; 309(3): 159-169.
- 2Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006; 29(12): 2739-2748.
- 3Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009; 10(1): 33-37.
- 4Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care. 2012; 27(2): 132-137.
- 5Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015; 373(6): 548-559.
- 6Deeter KH, Roberts JS, Bradford H, et al. Hypertension despite dehydration during severe pediatric diabetic ketoacidosis. Pediatr Diabetes. 2011; 12(4 pt 1): 295-301.
- 7McDonnell CM, Pedreira CC, Vadamalayan B, Cameron FJ, Werther GA. Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation? Pediatr Diabetes. 2005; 6(2): 90-94.
- 8Carlotti AP, St George-Hyslop C, Guerguerian AM, Bohn D, Kamel KS, Halperin M. Occult risk factor for the development of cerebral edema in children with diabetic ketoacidosis: possible role for stomach emptying. Pediatr Diabetes. 2009; 10(8): 522-533.
- 9Atchley D, Loeb R, Richards D Jr, Benedict E, Driscoll M. On diabetic ketoacidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest. 1933; 12: 297-326.
- 10Nabarro J, Spencer A, Stowers J. Metabolic studies in severe diabetic ketosis. Q J Med. 1952; 82: 225-248.
- 11Butler A, Talbot N, Burnett C, Stanbury J, MacLachlan E. Metabolic studies in diabetic coma. Trans Assoc Am Phys. 1947; 60: 102-109.
- 12Danowski T, Peters J, Rathbun J, Quashnock J, Greenman L. Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. J Clin Invest. 1949; 28: 1-9.
- 13Darrow D, Pratt E. Retention of water and electrolyte during recovery in a patient with diabetic acidosis. J Pediatr. 1952; 41: 688-696.
- 14Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957; 19(5): 823-832.
- 15Friedman AL. Pediatric hydration therapy: historical review and a new approach. Kidney Int. 2005; 67(1): 380-388.
- 16Collier S, Gura K, deLoid L, Dalton M. L S. Parenteral Nutrition. In: K Sonneville, C Duggan, eds. Manual of Pediatric Nutrition. 5th ed. Shelton, CT: People's Medical Publishing House-USA; 2014: 196-248.
- 17Darrow DC. The physiologic basis for estimating requirements for parenteral fluids. Pediatr Clin N Am. 1959; 6(1): 29-41.
- 18Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004; 89(2): 188-194.
- 19Sheikh-Ali M, Karon BS, Basu A, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008; 31(4): 643-647.
- 20Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab. 1993; 76(5): 1192-1198.
- 21Pinkney JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group. Diabetologia. 1994; 37(1): 70-74.
- 22Bas VN, Uytun S, Torun YA. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting. J Pediatr Endocrinol Metab. 2015; 28(3–4): 333-335.
- 23Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015; 38(9): 1687-1693.
- 24Goldenberg RM, Berard LD, Cheng AY, et al. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016; 38(12): 2654-2664.e1.
- 25Misaghian-Xanthos N, Shariff AI, Mekala K, et al. Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis: a case series from three academic institutions. Diabetes Care. 2017; 40(6): e65-e66.
- 26von Oettingen J, Wolfsdorf J, Feldman HA, Rhodes ET. Use of serum bicarbonate to substitute for venous pH in new-onset diabetes. Pediatrics. 2015; 136(2): e371-e377.
- 27Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017; 376(15): 1419-1429.
- 28Ingelfinger JR, Jarcho JA. Increase in the incidence of diabetes and its implications. N Engl J Med. 2017; 376(15): 1473-1474.
- 29Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013; 56(7): 1471-1488.
- 30Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014; 133(4): e938-e945.
- 31 American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000; 105((3, pt 1)): 671-680.
- 32Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics. 2008; 121(5): e1258-e1266.
- 33Gungor N, Hannon T, Libman I, Bacha F, Arslanian S. Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin N Am. 2005; 52(6): 1579-1609.
- 34Klingensmith GJ, Connor CG, Ruedy KJ, et al. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2016; 17(4): 266-273.
- 35Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990; 11(10): 297-304.
- 36Morales AE, Rosenbloom AL. Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes. J Pediatr. 2004; 144(2): 270-273.
- 37Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA, Tamborlane WV. Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population. J Pediatr Endocrinol Metab. 2007; 20(10): 1115-1124.
- 38Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010; 156(2): 180-184.
- 39Bagdure D, Rewers A, Campagna E, Sills MR. Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA. Pediatr Diabetes. 2013; 14(1): 18-24.
- 40Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010; 11(3): 199-204.
- 41Zeitler P, Haqq A, Rosenbloom A, Glaser N. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr. 2011; 158(1): 9-14, 14.e1-2.
- 42Levy-Marchal C, Papoz L, de Beaufort C, et al. Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med. 1992; 9(3): 279-284.
- 43Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child. 1996; 75(5): 410-415.
- 44Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001; 44((suppl 3)): B75-B80.
- 45Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden – a 2-year paediatric population study. Diabet Med. 2007; 24(10): 1080-1085.
- 46Rodacki M, Pereira JR, Nabuco de Oliveira AM, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract. 2007; 78(2): 259-262.
- 47Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012; 55(11): 2878-2894.
- 48Fritsch M, Schober E, Rami-Merhar B, Hofer S, Frohlich-Reiterer E, Waldhoer T. Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011. J Pediatr. 2013; 163: 1484-8.e1.
- 49Zucchini S, Scaramuzza AE, Bonfanti R, et al. A multicenter retrospective survey regarding diabetic ketoacidosis management in Italian children with type 1 diabetes. J Diabetes Res. 2016; 2016: 5719470.
- 50Letourneau LR, Carmody D, Wroblewski K, et al. Diabetes presentation in infancy: high risk of diabetic ketoacidosis. Diabetes Care. 2017; 40(10): e147-e148.
- 51Quinn M, Fleischman A, Rosner B, Nigrin DJ, Wolfsdorf JI. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006; 148(3): 366-371.
- 52Bui H, To T, Stein R, Fung K, Daneman D. Is diabetic ketoacidosis at disease onset a result of missed diagnosis? J Pediatr. 2010; 156(3): 472-477.
- 53Szypowska A, Skorka A. The risk factors of ketoacidosis in children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2011; 12(4, pt 1): 302-306.
- 54Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care. 1999; 22(12): 1950-1955.
- 55Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011; 343: d4092.
- 56Rosilio M, Cotton JB, Wieliczko MC, et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care. 1998; 21(7): 1146-1153.
- 57Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr. 1998; 87(5): 537-541.
- 58Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland Medicines Monitoring Unit. Lancet. 1997; 350(9090): 1505-1510.
- 59Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002; 287(19): 2511-2518.
- 60Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes. 2013; 14(6): 447-454.
- 61Maahs DM, Hermann JM, Holman N, et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015; 38(10): 1876-1882.
- 62Hermann JM, Meusers M, Bachran R, et al. Self-reported regular alcohol consumption in adolescents and emerging adults with type 1 diabetes: A neglected risk factor for diabetic ketoacidosis? Multicenter analysis of 29 630 patients from the DPV registry. Pediatr Diabetes. 2017; 18(8): 817-823.
- 63Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics. 2008; 121(5): e1133-e1138.
- 64Karges B, Schwandt A, Heidtmann B, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017; 318(14): 1358-1366.
- 65Kleinman ME, Chameides L, Schexnayder SM, et al. Pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2010; 126(5): e1361-e1399.
- 66Kleinman ME, de Caen AR, Chameides L, et al. Pediatric basic and advanced life support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Pediatrics. 2010; 126(5): e1261-e1318.
- 67Wiggam MI, O'Kane MJ, Harper R, et al. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care. 1997; 20(9): 1347-1352.
- 68Vanelli M, Chiari G, Capuano C, Iovane B, Bernardini A, Giacalone T. The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab. 2003; 16(5–6): 312-316.
- 69Ham MR, Okada P, White PC. Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. Pediatr Diabetes. 2004; 5(1): 39-43.
- 70Rewers A, McFann K, Chase HP. Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children. Diabetes Technol Ther. 2006; 8(6): 671-676.
- 71Prisco F, Picardi A, Iafusco D, et al. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes. 2006; 7(4): 223-228.
- 72Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007; 8(3): 150-156.
- 73Klocker AA, Phelan H, Twigg SM, Craig ME. Blood beta-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in type 1 diabetes: a systematic review. Diabet Med. 2013; 30(7): 818-824.
- 74Koves IH, Neutze J, Donath S, et al. The accuracy of clinical assessment of dehydration during diabetic ketoacidosis in childhood. Diabetes Care. 2004; 27(10): 2485-2487.
- 75Sottosanti M, Morrison GC, Singh RN, et al. Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child. 2012; 97(2): 96-100.
- 76Ugale J, Mata A, Meert KL, Sarnaik AP. Measured degree of dehydration in children and adolescents with type 1 diabetic ketoacidosis. Pediatr Crit Care Med. 2012; 13(2): e103-e107.
- 77Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated? JAMA. 2004; 291(22): 2746-2754.
- 78Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2(7872): 81-84.
- 79Tasker RC, Lutman D, Peters MJ. Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005; 6(4): 405-411.
- 80Davids MR, Edoute Y, Stock S, Halperin ML. Severe degree of hyperglycaemia: insights from integrative physiology. QJM. 2002; 95(2): 113-124.
- 81Malone JI, Brodsky SJ. The value of electrocardiogram monitoring in diabetic ketoacidosis. Diabetes Care. 1980; 3(4): 543-547.
- 82Soler NG, Bennett MA, Fitzgerald MG, Malins JM. Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes. 1974; 23(7): 610-615.
- 83Gutierrez JA, Bagatell R, Samson MP, Theodorou AA, Berg RA. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med. 2003; 31(1): 80-83.
- 84Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics. 2004; 113(1, pt 1): e57-e60.
- 85Chima RS, Hanson SJ. Venous thromboembolism in critical illness and trauma: pediatric perspectives. Front Pediatr. 2017; 5: 47.
- 86Flood RG, Chiang VW. Rate and prediction of infection in children with diabetic ketoacidosis. Am J Emerg Med. 2001; 19(4): 270-273.
- 87Monroe KW, King W, Atchison JA. Use of PRISM scores in triage of pediatric patients with diabetic ketoacidosis. Am J Manag Care. 1997; 3(2): 253-258.
- 88Bonadio WA, Gutzeit MF, Losek JD, Smith DS. Outpatient management of diabetic ketoacidosis. Am J Dis Child. 1988; 142(4): 448-450.
- 89Linares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emerg Care. 1996; 12(5): 347-351.
- 90Yu HY, Agus M, Kellogg MD. Clinical utility of Abbott precision Xceed pro(R) ketone meter in diabetic patients. Pediatr Diabetes. 2011; 12(7): 649-655.
- 91Lutfi R, Huang J, Wong HR. Plasmapheresis to treat hypertriglyceridemia in a child with diabetic ketoacidosis and pancreatitis. Pediatrics. 2012; 129(1): e195-e198.
- 92Oh G, Anderson S, Tancredi D, Kuppermann N, Glaser N. Hyponatremia in pediatric diabetic ketoacidosis: reevaluating the correction factor for hyperglycemia. Arch Pediatr Adolesc Med. 2009; 163(8): 771-772.
- 93Halperin ML, Goldstein MB. Fluid, Electrolyte, and Acid-Base Physiology. 3rd ed. Philadelphia, PA: Saunders; 1999.
- 94Love AH, Phillips RA. Measurement of dehydration in cholera. J Infect Dis. 1969; 119(1): 39-42.
- 95Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med. 1994; 148(10): 1046-1052.
- 96Napolova O, Urbach S, Davids MR, Halperin ML. Assessing the degree of extracellular fluid volume contraction in a patient with a severe degree of hyperglycaemia. Nephrol Dial Transplant. 2003; 18(12): 2674-2677.
- 97Halperin ML, Maccari C, Kamel KS, Carlotti AP, Bohn D. Strategies to diminish the danger of cerebral edema in a pediatric patient presenting with diabetic ketoacidosis. Pediatr Diabetes. 2006; 7(4): 191-195.
- 98Katz MA. Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression. N Engl J Med. 1973; 289(16): 843-844.
- 99Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999; 106(4): 399-403.
- 100Harris GD, Fiordalisi I, Harris WL, Mosovich LL, Finberg L. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr. 1990; 117: 22-31.
- 101Hale PM, Rezvani I, Braunstein AW, Lipman TH, Martinez N, Garibaldi L. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes. Acta Paediatr. 1997; 86(6): 626-631.
- 102Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001; 344(4): 264-269.
- 103Brown TB. Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor? Emerg Med J. 2004; 21(2): 141-144.
- 104Glaser NS, Ghetti S, Casper TC, Dean JM, Kuppermann N. Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial. Pediatr Diabetes. 2013; 14: 435-446.
- 105Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006; 49(9): 2002-2009.
- 106Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med. 2018; 378: 2275-2287.
- 107Dunger DB, Sperling MA, Acerini CL, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004; 113(2): e133-e140.
- 108Adrogue HJ, Barrero J, Eknoyan G. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989; 262(15): 2108-2113.
- 109Mel JM, Werther GA. Incidence and outcome of diabetic cerebral oedema in childhood: are there predictors? J Paediatr Child Health. 1995; 31(1): 17-20.
- 110Wagner A, Risse A, Brill HL, et al. Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application. Diabetes Care. 1999; 22(5): 674-677.
- 111Toledo JD, Modesto V, Peinador M, et al. Sodium concentration in rehydration fluids for children with ketoacidotic diabetes: effect on serum sodium concentration. J Pediatr. 2009; 154: 895-900.
- 112White PC, Dickson BA. Low morbidity and mortality in children with diabetic ketoacidosis treated with isotonic fluids. J Pediatr. 2013; 163(3): 761-766.
- 113Nallasamy K, Jayashree M, Singhi S, Bansal A. Low-dose vs standard-dose insulin in pediatric diabetic ketoacidosis: a randomized clinical trial. JAMA Pediatr. 2014; 168: 999-1005.
- 114Yung M, Letton G, Keeley S. Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis. J Paediatr Child Health. 2017; 53(1): 12-17.
- 115Rother KI, Schwenk WF 2nd. Effect of rehydration fluid with 75 mmol/L of sodium on serum sodium concentration and serum osmolality in young patients with diabetic ketoacidosis. Mayo Clin Proc. 1994; 69(12): 1149-1153.
- 116Felner EI, White PC. Improving management of diabetic ketoacidosis in children. Pediatrics. 2001; 108(3): 735-740.
- 117Basnet S, Venepalli PK, Andoh J, Verhulst S, Koirala J. Effect of normal saline and half normal saline on serum electrolytes during recovery phase of diabetic ketoacidosis. J Intensive Care Med. 2014; 29(1): 38-42.
- 118Fiordalisi I, Novotny WE, Holbert D, Finberg L, Harris GD. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes. 2007; 8(3): 142-149.
- 119Hoorn EJ, Carlotti AP, Costa LA, et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr. 2007; 150(5): 467-473.
- 120Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr. 1988; 113: 10-14.
- 121Adrogue HJ, Wilson H, Boyd AE 3rd, Suki WN, Eknoyan G. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982; 307(26): 1603-1610.
- 122Adrogue HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int. 1984; 25(4): 591-598.
- 123Taylor D, Durward A, Tibby SM, et al. The influence of hyperchloraemia on acid base interpretation in diabetic ketoacidosis. Intensive Care Med. 2006; 32(2): 295-301.
- 124Durward A, Skellett S, Mayer A, Taylor D, Tibby SM, Murdoch IA. The value of the chloride: sodium ratio in differentiating the aetiology of metabolic acidosis. Intensive Care Med. 2001; 27(5): 828-835.
- 125Oh MS, Carroll HJ, Goldstein DA, Fein IA. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med. 1978; 89(6): 925-927.
- 126Oh MS, Banerji MA, Carroll HJ. The mechanism of hyperchloremic acidosis during the recovery phase of diabetic ketoacidosis. Diabetes. 1981; 30(4): 310-313.
- 127Oh MS, Carroll HJ, Uribarri J. Mechanism of normochloremic and hyperchloremic acidosis in diabetic ketoacidosis. Nephron. 1990; 54(1): 1-6.
- 128von Oettingen JE, Rhodes ET, Wolfsdorf JI. Resolution of ketoacidosis in children with new onset diabetes: evaluation of various definitions. Diabetes Res Clin Pract. 2017; 135: 76-84.
- 129Chua HR, Venkatesh B, Stachowski E, et al. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care. 2012; 27(2): 138-145.
- 130Waldhausl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes. 1979; 28(6): 577-584.
- 131Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes. 1981; 30(6): 510-518.
- 132Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988; 37(11): 1470-1477.
- 133Kitabchi AE. Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diabetes Metab Rev. 1989; 5(4): 337-363.
- 134Martin MM, Martin AA. Continuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children. J Pediatr. 1976; 89(4): 560-564.
- 135Edwards GA, Kohaut EC, Wehring B, Hill LL. Effectiveness of low-dose continuous intravenous insulin infusion in diabetic ketoacidosis. A prospective comparative study. J Pediatr. 1977; 91(5): 701-705.
- 136Drop SL, Duval-Arnould JM, Gober AE, Hersh JH, McEnery PT, Knowles HC. Low-dose intravenous insulin infusion versus subcutaneous insulin injection: a controlled comparative study of diabetic ketoacidosis. Pediatrics. 1977; 59(5): 733-738.
- 137Lightner ES, Kappy MS, Revsin B. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children. Pediatrics. 1977; 60(5): 681-688.
- 138Perkin RM, Marks JF. Low-dose continuous intravenous insulin infusion in childhood diabetic ketoacidosis. Clin Pediatr (Phila). 1979; 18(9): 540-545-8.
- 139Kappy MS, Lightner ES. Low-dose intravenous insulin in the treatment of diabetic ketoacidosis. Am J Dis Child. 1979; 133(5): 523-525.
- 140Burghen GA, Etteldorf JN, Fisher JN, Kitabchi AQ. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care. 1980; 3(1): 15-20.
- 141Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008; 93(5): 1541-1552.
- 142Lindsay R, Bolte RG. The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis. Pediatr Emerg Care. 1989; 5(2): 77-79.
- 143Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet. 1987; 2(8554): 306-308.
- 144Soler NG, FitzGerald MG, Wright AD, Malins JM. Comparative study of different insulin regimens in management of diabetic ketoacidosis. Lancet. 1975; 2(7947): 1221-1224.
- 145Puttha R, Cooke D, Subbarayan A, et al. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes. 2010; 11: 12-17.
- 146Al Hanshi S, Shann F. Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011; 12(2): 137-140.
- 147Wang J, Barbry P, Maiyar AC, et al. SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol. 2001; 280(2): F303-F313.
- 148Tallini NY, Stoner LC. Amiloride-sensitive sodium current in everted Ambystoma initial collecting tubule: short-term insulin effects. Am J Physiol Cell Physiol. 2002; 283(4): C1171-C1181.
- 149McCormick JA, Bhalla V, Pao AC, Pearce D. SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Phys Ther. 2005; 20: 134-139.
- 150Tiwari S, Nordquist L, Halagappa VK, Ecelbarger CA. Trafficking of ENaC subunits in response to acute insulin in mouse kidney. Am J Physiol Renal Physiol. 2007; 293(1): F178-F185.
- 151Frindt G, Palmer LG. Effects of insulin on Na and K transporters in the rat CCD. Am J Physiol Renal Physiol. 2012; 302(10): F1227-F1233.
- 152Carlotti AP, St George-Hyslop C, Bohn D, Halperin ML. Hypokalemia during treatment of diabetic ketoacidosis: clinical evidence for an aldosterone-like action of insulin. J Pediatr. 2013; 163(1): 207-212.e1.
- 153Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med. 1977; 297(5): 238-241.
- 154Sacks HS, Shahshahani M, Kitabchi AE, Fisher JN, Young RT. Similar responsiveness of diabetic ketoacidosis to low-dose insulin by intramuscular injection and albumin-free infusion. Ann Intern Med. 1979; 90(1): 36-42.
- 155Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004; 117(5): 291-296.
- 156Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004; 27(8): 1873-1878.
- 157Della Manna T, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005; 28(8): 1856-1861.
- 158Savoldelli RD, Farhat SC, Manna TD. Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department. Diabetol Metab Syndr. 2010; 2: 41.
- 159Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2017; 18(4): 290-296.
- 160Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986; 65(3): 163-172.
- 161DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Phys. 1980; 238(5): E421-E427.
- 162Tattersall RB. A paper which changed clinical practice (slowly). Jacob holler on potassium deficiency in diabetic acidosis (1946). Diabet Med. 1999; 16(12): 978-984.
- 163Davis SM, Maddux AB, Alonso GT, Okada CR, Mourani PM, Maahs DM. Profound hypokalemia associated with severe diabetic ketoacidosis. Pediatr Diabetes. 2016; 17: 61-65.
- 164Guest G. Organic phosphates of the blood and mineral metabolism in diabetic acidosis. Am J Dis Child. 1942; 64: 401-412.
- 165Guest G, Rapoport S. Electrolytes of blood plasma and cells in diabetic acidosis and during recovery. Proc Amer Diab Assoc. 1947; 7: 95-115.
- 166Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism. 1979; 28(3): 191-194.
- 167Alberti KG, Emerson PM, Darley JH, Hockaday TD. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet. 1972; 2(7774): 391-395.
- 168Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977; 137(2): 203-220.
- 169O'Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med. 1977; 297(17): 901-903.
- 170Gibby OM, Veale KE, Hayes TM, Jones JG, Wardrop CA. Oxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin-oxygen affinity in diabetic ketoacidosis. Diabetologia. 1978; 15(5): 381-385.
- 171Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes. 1980; 29(2): 87-95.
- 172Wilson HK, Keuer SP, Lea AS, Boyd AE 3rd, Eknoyan G. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982; 142(3): 517-520.
- 173Becker DJ, Brown DR, Steranka BH, Drash AL. Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis. Am J Dis Child. 1983; 137(3): 241-246.
- 174Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983; 57(1): 177-180.
- 175Clerbaux T, Reynaert M, Willems E, Frans A. Effect of phosphate on oxygen-hemoglobin affinity, diphosphoglycerate and blood gases during recovery from diabetic ketoacidosis. Intensive Care Med. 1989; 15(8): 495-498.
- 176Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet. 1998; 352(9125): 391-396.
- 177Singhal PC, Kumar A, Desroches L, Gibbons N, Mattana J. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med. 1992; 92(5): 458-464.
- 178Kutlu AO, Kara C, Cetinkaya S. Rhabdomyolysis without detectable myoglobulinuria due to severe hypophosphatemia in diabetic ketoacidosis. Pediatr Emerg Care. 2011; 27(6): 537-538.
- 179Bohannon NJ. Large phosphate shifts with treatment for hyperglycemia. Arch Intern Med. 1989; 149(6): 1423-1425.
- 180de Oliveira Iglesias SB, Pons Leite H, de Carvalho WB. Hypophosphatemia-induced seizure in a child with diabetic ketoacidosis. Pediatr Emerg Care. 2009; 25(12): 859-861.
- 181Zipf WB, Bacon GE, Spencer ML, Kelch RP, Hopwood NJ, Hawker CD. Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care. 1979; 2(3): 265-268.
- 182Winter RJ, Harris CJ, Phillips LS, Green OC. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med. 1979; 67(5): 897-900.
- 183Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed). 1984; 289(6451): 1035-1038.
- 184Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986; 105(6): 836-840.
- 185Okuda Y, Adrogue HJ, Field JB, Nohara H, Yamashita K. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996; 81(1): 314-320.
- 186Green SM, Rothrock SG, Ho JD, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998; 31(1): 41-48.
- 187Assal JP, Aoki TT, Manzano FM, Kozak GP. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1974; 23(5): 405-411.
- 188Ohman JL Jr, Marliss EB, Aoki TT, Munichoodappa CS, Khanna VV, Kozak GP. The cerebrospinal fluid in diabetic ketoacidosis. N Engl J Med. 1971; 284(6): 283-290.
- 189Soler NG, Bennett MA, Dixon K, FitzGerald MG, Malins JM. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet. 1972; 2(7779): 665-667.
- 190Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med. 1983; 75(2): 263-268.
- 191Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med. 1987; 106(4): 615-618.
- 192Shankar V, Haque A, Churchwell KB, Russell W. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intensive Care Med. 2007; 33(7): 1173-1178.
- 193Harrison VS, Rustico S, Palladino AA, Ferrara C, Hawkes CP. Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes. 2017; 18(8): 742-748.
- 194Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002; 25(9): 1591-1596.
- 195Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999; 81(4): 318-323.
- 196Decourcey DD, Steil GM, Wypij D, Agus MS. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatr Crit Care Med. 2013; 14(7): 694-700.
- 197Saydah SH, Imperatore G, Geiss LS, Gregg E. Diabetes death rates among youths aged ≤19 years: United States, 1968–2009. Morb Mortal Wkly Rep. 2012; 61(43): 869-872.
- 198Morgan E, Black CR, Abid N, Cardwell CR, McCance DR, Patterson CC. Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989-2012: A population-based cohort study. Pediatr Diabetes. 2018; 19(1): 166-170.
- 199Gibb FW, Teoh WL, Graham J, Lockman KA. Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia. 2016; 59(10): 2082-2087.
- 200Sperling MA. Diabetes: recurrent DKA – for whom the bell tolls. Nat Rev Endocrinol. 2016; 12(10): 562-564.
- 201Daneman D. Diabetes-related mortality. A pediatrician's view. Diabetes Care. 2001; 24(5): 801-802.
- 202Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001; 85(1): 16-22.
- 203Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005; 146(5): 688-692.
- 204Ghetti S, Lee JK, Sims CE, Demaster DM, Glaser NS. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr. 2010; 156(1): 109-114.
- 205Nadebaum C, Scratch SE, Northam EA, Cameron FJ, Diabetic Ketoacidosis and Brain Injury Study Group. Clinical utility of mental state screening as a predictor of intellectual outcomes 6 months after diagnosis of type 1 diabetes. Pediatr Diabetes. 2012; 13(8): 632-637.
- 206Cameron FJ, Scratch SE, Nadebaum C, et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care. 2014; 37(6): 1554-1562.
- 207Shalitin S, Fisher S, Yackbovitch-Gavan M, et al. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control. Pediatr Diabetes. 2018; 19(2): 320-328.
- 208Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care. 2017; 40(9): 1249-1255.
- 209Yasuda K, Hayashi M, Murayama M, Yamakita N. Acidosis-induced hypochloremic alkalosis in diabetic ketoacidosis confirmed by the modified base excess method. J Clin Endocrinol Metab. 2016; 101(6): 2390-2395.
- 210Cooper MR, Turner RA Jr, Hutaff L, Prichard R. Diabetic keto-acidosis complicated by disseminated intravascular coagulation. South Med J. 1973; 66(6): 653-657.
- 211Keane S, Gallagher A, Ackroyd S, McShane MA, Edge JA. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child. 2002; 86(3): 204-205.
- 212Ho J, Mah JK, Hill MD, Pacaud D. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes. 2006; 7(2): 116-121.
- 213Moye J, Rosenbloom AL, Silverstein J. Clinical predictors of mucormycosis in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2002; 15(7): 1001-1004.
- 214Watson JP, Barnett AH. Pneumomediastinum in diabetic ketoacidosis. Diabet Med. 1989; 6(2): 173-174.
- 215Hursh BE, Ronsley R, Islam N, Mammen C, Panagiotopoulos C. Acute kidney injury in children with type 1 diabetes hospitalized for diabetic ketoacidosis. JAMA Pediatr. 2017; 171(5): e170020.
- 216Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr. 2004; 145(1): 122-124.
- 217Glaser NS, Wootton-Gorges SL, Buonocore MH, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes. 2006; 7(2): 75-80.
- 218Glaser NS, Marcin JP, Wootton-Gorges SL, et al. Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging. J Pediatr. 2008; 153(4): 541-546.
- 219Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985; 312(18): 1147-1151.
- 220Hoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol. 1988; 9(4): 733-739.
- 221Sperling MA. Cerebral edema in diabetic ketoacidosis: an underestimated complication? Pediatr Diabetes. 2006; 7(2): 73-74.
- 222Arieff AI, Kleeman CR. Studies on mechanisms of cerebral edema in diabetic comas. Effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits. J Clin Invest. 1973; 52(3): 571-583.
- 223Arieff AI, Kleeman CR. Cerebral edema in diabetic comas. II. Effects of hyperosmolality, hyperglycemia and insulin in diabetic rabbits. J Clin Endocrinol Metab. 1974; 38(6): 1057-1067.
- 224Prockop LD. Hyperglycemia, polyol accumulation, and increased intracranial pressure. Arch Neurol. 1971; 25(2): 126-140.
- 225Harris GD, Fiordalisi I, Finberg L. Safe management of diabetic ketoacidemia. J Pediatr. 1988; 113: 65-67.
- 226Kamel KS, Halperin ML. Acid-base problems in diabetic ketoacidosis. N Engl J Med. 2015; 372(6): 546-554.
- 227Glaser NS, Wootton-Gorges SL, Marcin JP, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr. 2004; 145(2): 164-171.
- 228Glaser N, Yuen N, Anderson SE, Tancredi DJ, O'Donnell ME. Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. Diabetes. 2010; 59(3): 702-709.
- 229Yuen N, Anderson SE, Glaser N, Tancredi DJ, O'Donnell ME. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes. 2008; 57(10): 2588-2594.
- 230Tasker RC, Acerini CL. Cerebral edema in children with diabetic ketoacidosis: vasogenic rather than cellular? Pediatr Diabetes. 2014; 15(4): 261-270.
- 231Rosenbloom AL, Schatz DA, Krischer JP, et al. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab. 2000; 85(2): 494-522.
- 232Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009; 10(8): 534-541.
- 233Hoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 2009; 1254: 138-148.
- 234Vavilala MS, Richards TL, Roberts JS, et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med. 2010; 11(3): 332-338.
- 235Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 1990; 13(1): 22-33.
- 236Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children [letter]. Lancet. 1990; 336(8706): 64.
- 237Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol. 1999; 21(4): 721-727.
- 238Durr JA, Hoffman WH, Sklar AH, el Gammal T, Steinhart CM. Correlates of brain edema in uncontrolled IDDM. Diabetes. 1992; 41(5): 627-632.
- 239Durward A, Ferguson LP, Taylor D, Murdoch IA, Tibby SM. The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis. Arch Dis Child. 2011; 96: 50-57.
- 240Bureau MA, Begin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980; 96(6): 968-973.
- 241Deeb L. Development of fatal cerebral edema during outpatient therapy for diabetic ketoacidosis. Pract Diab. 1989; 6: 212-213.
10.1002/pdi.1960060507 Google Scholar
- 242Glasgow AM. Devastating cerebral edema in diabetic ketoacidosis before therapy [letter]. Diabetes Care. 1991; 14(1): 77-78.
- 243Couch RM, Acott PD, Wong GW. Early onset fatal cerebral edema in diabetic ketoacidosis. Diabetes Care. 1991; 14(1): 78-79.
- 244Fiordalisi I, Harris GD, Gilliland MG. Prehospital cardiac arrest in diabetic ketoacidemia: why brain swelling may lead to death before treatment. J Diabetes Complicat. 2002; 16(3): 214-219.
- 245Edge JA. Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause? Diabetes Metab Res Rev. 2000; 16(5): 316-324.
- 246Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004; 27(7): 1541-1546.
- 247Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics. 1982; 69(1): 87-90.
- 248Shabbir N, Oberfield SE, Corrales R, Kairam R, Levine LS. Recovery from symptomatic brain swelling in diabetic ketoacidosis. Clin Pediatr (Phila). 1992; 31(9): 570-573.
- 249Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes. 2001; 2: 109-114.
- 250Curtis JR, Bohn D, Daneman D. Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA). Pediatr Diabetes. 2001; 2(4): 191-194.
- 251Kamat P, Vats A, Gross M, Checchia PA. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatr Crit Care Med. 2003; 4(2): 239-242.
- 252Tasker RC, Burns J. Hypertonic saline therapy for cerebral edema in diabetic ketoacidosis: no change yet, please. Pediatr Crit Care Med. 2014; 15(3): 284-285.
- 253Soto-Rivera CL, Asaro LA, Agus MS, DeCourcey DD. Suspected cerebral edema in diabetic ketoacidosis: is there still a role for head CT in treatment decisions? Pediatr Crit Care Med. 2017; 18(3): 207-212.
- 254Kanter RK, Oliphant M, Zimmerman JJ, Stuart MJ. Arterial thrombosis causing cerebral edema in association with diabetic ketoacidosis. Crit Care Med. 1987; 15(2): 175-176.
- 255Roe TF, Crawford TO, Huff KR, Costin G, Kaufman FR, Nelson MD Jr. Brain infarction in children with diabetic ketoacidosis. J Diabetes Complicat. 1996; 10(2): 100-108.
- 256Rosenbloom AL. Fatal cerebral infarctions in diabetic ketoacidosis in a child with previously unknown heterozygosity for factor V Leiden deficiency. J Pediatr. 2004; 145(4): 561-562.
- 257Fourtner SH, Weinzimer SA, Levitt Katz LE. Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes. Pediatr Diabetes. 2005; 6(3): 129-135.
- 258Kronan K, Normal ME. Renal and electrolyte emergencies. In: GR Fleisher, S Ludwig, eds. Textbook of Emergency Medicine. 4th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2000.
- 259Matz R. Management of the hyperosmolar hyperglycemic syndrome. Am Fam Physician. 1999; 60(5): 1468-1476.
- 260Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin N Am. 2000; 29(4): 683-705.
- 261Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006; 118(5): 2119-2125.
- 262Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003; 111(6, pt 1): 1447-1452.
- 263Carcillo JA, Tasker RC. Fluid resuscitation of hypovolemic shock: acute medicine's great triumph for children. Intensive Care Med. 2006; 32(7): 958-961.
- 264Kilbane BJ, Mehta S, Backeljauw PF, Shanley TP, Crimmins NA. Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. Pediatr Crit Care Med. 2006; 7(2): 169-173.
- 265Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med. 2006; 23(3): 278-284.
- 266Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin N Am. 2000; 29(4): 707-723.
- 267Hoffman WH, O'Neill P, Khoury C, Bernstein SS. Service and education for the insulin-dependent child. Diabetes Care. 1978; 1(5): 285-288.
- 268Drozda DJ, Dawson VA, Long DJ, Freson LS, Sperling MA. Assessment of the effect of a comprehensive diabetes management program on hospital admission rates of children with diabetes mellitus. Diabetes Educ. 1990; 16(5): 389-393.
- 269Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000; 137(1): 107-113.
- 270Golden MP, Herrold AJ, Orr DP. An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population. J Pediatr. 1985; 107(2): 195-200.
- 271Pinhas-Hamiel O, Sperling M. Diabetic ketoacidosis. In: Z Hochberg, ed. Practical Algorithms in Pediatric Endocrinology. 3rd ed. Basel, Switzerland: Karger; 2017: 112-113.
